The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

A comprehensive US analysis showed that progress in multiple myeloma survival has not been shared equally, with significant disparities persisting despite improved therapies.

Novel drug regimens, autologous stem cell transplant (ASCT), and modern supportive care are prolonging remission, improving ...

Johnson & Johnson (JNJ) stock in focus as Darzalex SC developed with Halozyme (HALO) and Genmab (GMAB) receives EU nod for ...

Researchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, ...

Multiple myeloma is predominantly a disease of the elderly, with the median age at diagnosis about 70; one-third of patients ...